Pioneering access for patients.
Sandoz is a global leader in generic pharmaceuticals and biosimilars and a division of the Novartis Group. Our mission is to discover new ways to improve and extend people’s lives. Sandoz contributes to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. That is our purpose.
Our global portfolio comprises approximately 1000 molecules, covering all major therapeutic areas, which accounted for 2019 sales of around USD 10 billion. Our broad offering translates into substantial and ongoing savings for patients and payors, which help to ensure the sustainability of healthcare systems in the face of significant budgetary pressures, while also freeing up funding for innovative medicines.
Our products reach more than 500 million patients and our aspiration is to reach one billion. Our broad portfolio is spearheaded by our global leadership position in both biosimilars, the “cutting edge” of innovative off-patent medicines, and generic antibiotics, the foundation of global healthcare systems. We also run a broad range of targeted corporate responsibility programs to increase access to medicine, medical information and appropriate medical training for healthcare professionals.
Working at Sandoz
Sandoz is uniquely positioned as both a global generics leader in its own right and part of the worldwide Novartis Group. As one of three industry-leading divisions that have innovation power backed by global scale, Sandoz is an increasingly important strategic driver for Novartis overall.
Our single greatest differentiator is our entrepreneurial culture and the quality and commitment of our associates. We combine the resources and long-term vision of a global pharmaceutical leader with the energy, drive and flexibility of a start-up. Many of our top leaders cite this deep-rooted entrepreneurial culture as one of the main reasons they choose to work at Sandoz.
Sandoz strives to provide a challenging learning environment for all associates across the organization. By investing in the development of our people, we fuel our current and future growth and reinforce our leadership in the global generics industry.